<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37039708</PMID><DateCompleted><Year>2023</Year><Month>06</Month><Day>19</Day></DateCompleted><DateRevised><Year>2023</Year><Month>11</Month><Day>20</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2165-0497</ISSN><JournalIssue CitedMedium="Internet"><Volume>11</Volume><Issue>3</Issue><PubDate><Year>2023</Year><Month>Jun</Month><Day>15</Day></PubDate></JournalIssue><Title>Microbiology spectrum</Title><ISOAbbreviation>Microbiol Spectr</ISOAbbreviation></Journal><ArticleTitle>The Clinical Performance of the BioCode Respiratory Pathogen Panel for the Detection of Viruses and Bacteria from Nasopharyngeal Swabs.</ArticleTitle><Pagination><StartPage>e0404422</StartPage><MedlinePgn>e0404422</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e04044-22</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1128/spectrum.04044-22</ELocationID><Abstract><AbstractText>Early detection of microbial pathogens causing respiratory tract infection plays a crucial role in clinical management. The BioCode Respiratory Pathogen Panel (BioCode RPP) utilizes reverse transcriptase PCR (RT-PCR) in combination with barcoded magnetic beads to amplify, detect, and identify respiratory pathogens. This panel qualitatively detects and identifies 14 viruses, including influenza virus A with H1 pdm09, H1, and H3 subtyping; influenza B; respiratory syncytial virus (RSV); human metapneumovirus; parainfluenza virus 1; parainfluenza virus 2; parainfluenza virus 3; parainfluenza virus 4; coronavirus (229E, NL63, OC43, and HKU1); adenovirus; and human rhinovirus/enterovirus, and 3 bacteria, including Chlamydia pneumoniae, Mycoplasma pneumoniae, and Bordetella pertussis. Reproducibility, which was assessed with contrived specimens containing 12 targets at 3 clinical sites, with 2 operators at each site for 5 days, was 99.4% for Flu A H3 and Flu B, 98.9% for RSV, and 100% for the remaining 9 targets assayed. A multicenter clinical trial evaluated the performance of the BioCode RPP with 2,647 nasopharyngeal swab specimens from 5 geographically distinct sites and revealed comparable performance between the BioCode RPP and FilmArray Respiratory Panel (FA-RP). Specifically, the positive percent agreements (PPAs) for various pathogens ranged between 80.8% and 100% compared with the FA-RP (1.7 and 2.0). Negative percent agreement ranged from 98.4% to 100% for BioCode RPP. The BioCode RPP also offers scalable automated testing capability of up to 96 specimens in a single run with total sample-to-result time under 5 h. The invalid rate of the BioCode RPP on initial testing was 1.0% (26/2,649). <b>IMPORTANCE</b> Early detection of microbial pathogens causing respiratory tract infection plays a crucial role in clinical management. The BioCode Respiratory Pathogen Panel (BioCode RPP) is a high-throughput test that utilizes RT-PCR in combination with barcoded magnetic beads to amplify, detect, and identify 17 respiratory pathogens, including 14 viruses and 3 bacteria. This study summarizes data generated from a multicenter clinical trial evaluating the performance of the BioCode RPP on 2,647 nasopharyngeal swab specimens from five geographically distinct sites.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Xin</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Memorial Sloan Kettering Cancer Center, New York, New York, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Sichuan Academy of Medicine &amp; Sichuan Provincial People's Hospital, Chengdu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Knoth</LastName><ForeName>Colleen</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Applied BioCode Inc., Santa Fe Springs, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pham</LastName><ForeName>Anh</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Applied BioCode Inc., Santa Fe Springs, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lima</LastName><ForeName>Amorce</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Tampa General Hospital, Tampa, Florida, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dominguez</LastName><ForeName>Rosario</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Pathology and Laboratory Medicine, Children's Hospital Los Angeles, Los Angeles, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ibarra-Flores</LastName><ForeName>Irvin</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department of Pathology and Laboratory Medicine, Children's Hospital Los Angeles, Los Angeles, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lopez</LastName><ForeName>Juan C</ForeName><Initials>JC</Initials><AffiliationInfo><Affiliation>Memorial Sloan Kettering Cancer Center, New York, New York, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Uy</LastName><ForeName>Dominic</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Tampa General Hospital, Tampa, Florida, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Silbert</LastName><ForeName>Suzane</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Tampa General Hospital, Tampa, Florida, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Patel</LastName><ForeName>Anami</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>PathAI Diagnostics, Memphis, Tennessee, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aye</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Applied BioCode Inc., Santa Fe Springs, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tang</LastName><ForeName>Yi-Wei</ForeName><Initials>YW</Initials><AffiliationInfo><Affiliation>Memorial Sloan Kettering Cancer Center, New York, New York, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dien Bard</LastName><ForeName>Jennifer</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0003-0524-9473</Identifier><AffiliationInfo><Affiliation>Department of Pathology and Laboratory Medicine, Children's Hospital Los Angeles, Los Angeles, California, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Keck School of Medicine, University of Southern California, Los Angeles, California, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>P30 CA008748</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016448">Multicenter Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>04</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Microbiol Spectr</MedlineTA><NlmUniqueID>101634614</NlmUniqueID><ISSNLinking>2165-0497</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014777" MajorTopicYN="Y">Virus Diseases</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015203" MajorTopicYN="N">Reproducibility of Results</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014780" MajorTopicYN="Y">Viruses</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001419" MajorTopicYN="N">Bacteria</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012141" MajorTopicYN="Y">Respiratory Tract Infections</DescriptorName><QualifierName UI="Q000382" MajorTopicYN="N">microbiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018113" MajorTopicYN="Y">Respiratory Syncytial Virus, Human</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009305" MajorTopicYN="N">Nasopharynx</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018184" MajorTopicYN="Y">Paramyxoviridae Infections</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">multiplex PCR</Keyword><Keyword MajorTopicYN="N">respiratory pathogens</Keyword><Keyword MajorTopicYN="N">scalable throughput</Keyword><Keyword MajorTopicYN="N">syndromic testing</Keyword></KeywordList><CoiStatement>The authors declare a conflict of interest. A.P. and M.A. are employees of Applied BioCode. C.K. was an employee of Applied BioCode.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>6</Month><Day>19</Day><Hour>13</Hour><Minute>8</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>4</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>4</Month><Day>11</Day><Hour>10</Hour><Minute>13</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>4</Month><Day>11</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37039708</ArticleId><ArticleId IdType="pmc">PMC10269715</ArticleId><ArticleId IdType="doi">10.1128/spectrum.04044-22</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Hanson KE, Azar MM, Banerjee R, Chou A, Colgrove RC, Ginocchio CC, Hayden MK, Holodiny M, Jain S, Koo S, Levy J, Timbrook TT, Caliendo AM, for the Diagnostics Committee of the Infectious Diseases Society of America (IDSA) . 2020. Molecular testing for acute respiratory tract infections: clinical and diagnostic recommendations from the IDSA’s diagnostics committee. Clin Infect Dis 71:2744–2751. doi:10.1093/cid/ciaa508.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciaa508</ArticleId><ArticleId IdType="pmc">PMC7454374</ArticleId><ArticleId IdType="pubmed">32369578</ArticleId></ArticleIdList></Reference><Reference><Citation>Schreckenberger PC, McAdam AJ. 2015. Point-counterpoint: large multiplex PCR panels should be first-line tests for detection of respiratory and intestinal pathogens. J Clin Microbiol 53:3110–3115. doi:10.1128/JCM.00382-15.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JCM.00382-15</ArticleId><ArticleId IdType="pmc">PMC4572537</ArticleId><ArticleId IdType="pubmed">25762770</ArticleId></ArticleIdList></Reference><Reference><Citation>Centers for Disease Control and Prevention. Summary of the 2017–2018 influenza season. https://www.cdc.gov/flu/about/season/flu-season-2017-2018.htm.</Citation></Reference><Reference><Citation>Centers for Disease Control and Prevention. Estimated flu-related illnesses, medical visits, hospitalizations, and deaths in the United States—2018–2019 flu season. https://www.cdc.gov/flu/about/burden/2018-2019.html.</Citation></Reference><Reference><Citation>Popowitch EB, Kaplan S, Wu Z, Tang YW, Miller MB. 2022. Comparative performance of the Luminex NxTAG respiratory pathogen panel, GenMark eSensor respiratory viral panel, and BioFire FilmArray respiratory panel. Microbiol Spectr 10:e01248-22. doi:10.1128/spectrum.01248-22.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/spectrum.01248-22</ArticleId><ArticleId IdType="pmc">PMC9431521</ArticleId><ArticleId IdType="pubmed">35766513</ArticleId></ArticleIdList></Reference><Reference><Citation>Leber AL, Everhart K, Daly JA, Hopper A, Harrington A, Schreckenberger P, McKinley K, Jones M, Holmberg K, Kensinger B. 2018. Multicenter evaluation of BioFire FilmArray respiratory panel 2 for detection of viruses and bacteria in nasopharyngeal swab samples. J Clin Microbiol 56:e01945-17. doi:10.1128/JCM.01945-17.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JCM.01945-17</ArticleId><ArticleId IdType="pmc">PMC5971546</ArticleId><ArticleId IdType="pubmed">29593057</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong DM, Blumberg DA, Lowe LG. 2006. Guidelines for the use of antibiotics in acute upper respiratory infections. Am Fam Physician 74:956–966.</Citation><ArticleIdList><ArticleId IdType="pubmed">17002029</ArticleId></ArticleIdList></Reference><Reference><Citation>Keske Ş, Ergönül Ö, Tutucu F, Karaaslan D, Palaoğlu E, Can F. 2018. The rapid diagnosis of viral respiratory tract infections and its impact on antimicrobial stewardship programs. Eur J Clin Microbiol Infect Dis 37:779–783. doi:10.1007/s10096-017-3174-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10096-017-3174-6</ArticleId><ArticleId IdType="pmc">PMC7087990</ArticleId><ArticleId IdType="pubmed">29332209</ArticleId></ArticleIdList></Reference><Reference><Citation>Krantz EM, Zier J, Stohs E, Ogimi C, Sweet A, Marquis S, Klaassen J, Pergam SA, Liu C. 2020. Antibiotic prescribing and respiratory viral testing for acute upper respiratory infections among adult patients at an ambulatory cancer center. Clin Infect Dis 70:1421–1428. doi:10.1093/cid/ciz409.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciz409</ArticleId><ArticleId IdType="pmc">PMC7108137</ArticleId><ArticleId IdType="pubmed">31095276</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang YW, Gonsalves S, Sun JY, Stiles J, Gilhuley KA, Mikhlina A, Dunbar SA, Babady NE, Zhang H. 2016. Clinical evaluation of the luminex NxTAG respiratory pathogen panel. J Clin Microbiol 54:1912–1914. doi:10.1128/JCM.00482-16.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JCM.00482-16</ArticleId><ArticleId IdType="pmc">PMC4922127</ArticleId><ArticleId IdType="pubmed">27122378</ArticleId></ArticleIdList></Reference><Reference><Citation>Esper FP, Spahlinger T, Zhou L. 2011. Rate and influence of respiratory virus co-infection on pandemic (H1N1) influenza disease. J Infect 63:260–266. doi:10.1016/j.jinf.2011.04.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2011.04.004</ArticleId><ArticleId IdType="pmc">PMC3153592</ArticleId><ArticleId IdType="pubmed">21546090</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi SH, Chung JW, Kim HR. 2015. Clinical relevance of multiple respiratory virus detection in adult patients with acute respiratory illness. J Clin Microbiol 53:1172–1177. doi:10.1128/JCM.03298-14.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JCM.03298-14</ArticleId><ArticleId IdType="pmc">PMC4365199</ArticleId><ArticleId IdType="pubmed">25631799</ArticleId></ArticleIdList></Reference><Reference><Citation>Franz A, Adams O, Willems R, Bonzel L, Neuhausen N, Schweizer-Krantz S, Ruggeberg JU, Willers R, Henrich B, Schroten H, Tenenbaum T. 2010. Correlation of viral load of respiratory pathogens and co-infections with disease severity in children hospitalized for lower respiratory tract infection. J Clin Virol 48:239–245. doi:10.1016/j.jcv.2010.05.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcv.2010.05.007</ArticleId><ArticleId IdType="pmc">PMC7185496</ArticleId><ArticleId IdType="pubmed">20646956</ArticleId></ArticleIdList></Reference><Reference><Citation>Aberle J, Aberle SW, Pracher E, Hutter HP, Kundi M, Popow-Kraupp T. 2005. Single versus dual respiratory virus infections in hospitalized infants: impact on clinical course of disease and interferon-γ response. Ped Infect Dis J 24:605–610. doi:10.1097/01.inf.0000168741.59747.2d.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.inf.0000168741.59747.2d</ArticleId><ArticleId IdType="pubmed">15999001</ArticleId></ArticleIdList></Reference><Reference><Citation>Goka EA, Vallely PJ, Mutton KJ, Klapper PE. 2014. Single and multiple respiratory virus infections and severity of respiratory disease: a systematic review. Paediatr Respir Rev 15:363–370. doi:10.1016/j.prrv.2013.11.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.prrv.2013.11.001</ArticleId><ArticleId IdType="pmc">PMC7106320</ArticleId><ArticleId IdType="pubmed">24361079</ArticleId></ArticleIdList></Reference><Reference><Citation>Mazur NI, Bont L, Cohen AL, Cohen C, von Gottberg A, Groome MJ, Hellferscee O, Klipstein-Grobusch K, Mekgoe O, Naby F, Moyes J, Tempia S, Treurnicht FK, Venter M, Walaza S, Wolter N, Madhi SA, South African Severe Acute Respiratory Illness (SARI) Surveillance Group . 2017. Severity of respiratory syncytial virus lower respiratory tract infection with viral coinfection in HIV-uninfected children. Clin Infect Dis 64:443–450. doi:10.1093/cid/ciw756.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciw756</ArticleId><ArticleId IdType="pmc">PMC5712444</ArticleId><ArticleId IdType="pubmed">27927871</ArticleId></ArticleIdList></Reference><Reference><Citation>Jerris RC, Williams SR, MacDonald HJ, et al. . 2015. Testing implications of varying targets for Bordetella pertussis: comparison of the FilmArray respiratory panel and the focus B. pertussis PCR assay. J Clin Pathol 68:394–396. doi:10.1136/jclinpath-2014-202833.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jclinpath-2014-202833</ArticleId><ArticleId IdType="pmc">PMC4413735</ArticleId><ArticleId IdType="pubmed">25742911</ArticleId></ArticleIdList></Reference><Reference><Citation>Guillot S, Mizrahi A, Armatys N, Chat L, Le Monnier A, Brisse S, Toubiana J. 2020. Low detection rate of Bordetella pertussis using the BioFire FilmArray respiratory panel 2plus. Open Forum Infect Dis 7:ofaa267. doi:10.1093/ofid/ofaa267.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ofid/ofaa267</ArticleId><ArticleId IdType="pmc">PMC7415305</ArticleId><ArticleId IdType="pubmed">32793765</ArticleId></ArticleIdList></Reference><Reference><Citation>Falsey AR, Walsh EE, Hayden FG. 2002. Rhinovirus and coronavirus infection-associated hospitalizations among older adults. J Infect Dis 185:1338–1341.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7109881</ArticleId><ArticleId IdType="pubmed">12001053</ArticleId></ArticleIdList></Reference><Reference><Citation>Gabutti G, De Motoli F, Sandri F, Toffoletto MV, Stefanati A. 2020. Viral respiratory infections in hematological patients. Infect Dis Ther 9:495–510. doi:10.1007/s40121-020-00313-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40121-020-00313-6</ArticleId><ArticleId IdType="pmc">PMC7339094</ArticleId><ArticleId IdType="pubmed">32638228</ArticleId></ArticleIdList></Reference><Reference><Citation>Park SW, Pons-Salort M, Messacar K, Cook C, Meyers L, Farrar J, Grenfell BT. 2021. Epidemiological dynamics of enterovirus D68 in the United States and implications for acute flaccid myelitis. Sci Transl Med 13:eabd2400. doi:10.1126/scitranslmed.abd2400.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.abd2400</ArticleId><ArticleId IdType="pubmed">33692131</ArticleId></ArticleIdList></Reference><Reference><Citation>Messacar K, Spence-Davizon E, Osborne C, Press C, Schreiner TL, Martin J, Messer R, Maloney J, Burakoff A, Barnes M, Rogers S, Lopez AS, Routh J, Gerber SI, Oberste MS, Nix WA, Abzug MJ, Tyler KL, Herlihy R, Dominguez SR. 2020. Clinical characteristics of enterovirus A71 neurological disease during an outbreak in children in Colorado, USA, in 2018: an observational cohort study. Lancet Infect Dis 20:230–239. doi:10.1016/S1473-3099(19)30632-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(19)30632-2</ArticleId><ArticleId IdType="pmc">PMC11284833</ArticleId><ArticleId IdType="pubmed">31859216</ArticleId></ArticleIdList></Reference><Reference><Citation>Song E, Wang H, Salamon D, Jaggi P, Leber A, Loeffelholz MJ. 2016. Performance characteristics of FilmArray respiratory panel v1.7 for detection of adenovirus in a large cohort of pediatric nasopharyngeal samples: one test may not fit all. J Clin Microbiol 54:1479–1486. doi:10.1128/JCM.00143-16.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JCM.00143-16</ArticleId><ArticleId IdType="pmc">PMC4879267</ArticleId><ArticleId IdType="pubmed">27008875</ArticleId></ArticleIdList></Reference><Reference><Citation>Li J, Tao Y, Tang M, Du B, Xia Y, Mo X, Cao Q. 2018. Rapid detection of respiratory organisms with the FilmArray respiratory panel in a large children’s hospital in China. BMC Infect Dis 18:510. doi:10.1186/s12879-018-3429-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-018-3429-6</ArticleId><ArticleId IdType="pmc">PMC6180626</ArticleId><ArticleId IdType="pubmed">30305033</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>